AbbVie Inc. Stock Outperforms Market Despite Losses On The Day

LogicMark Inc

Change company Symbol lookup

Select an option...

LGMK LogicMark Inc

$NQUSL50206015EUR Nasdaq Large Cap Commercial Vehicles

USCTU TKB Critical Technologies 1

SIEGY Siemens AG

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value

Company profile

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform. The Company builds technology to check, manage and monitor a loved ones health and safety remotely. Its PERS is a medical alert or medical alarm system, which is designed to indicate the presence of a threat that requires immediate attention and then immediately contacts a trusted family member and the emergency medical workforce. Its PERS devices incorporate two-way voice communication technology for remote monitoring. PERS transmits signals to an alarm monitoring medical team, which then departs for the location where the alarm was activated. Its PERS products include GUARDIAN ALERT 911 PLUS, FREEDOM ALERT, GUARDIAN ALERT 911, CONNECTED GUARDIAN and LifeSentry. Its PERS technologies are sold through dealers and distributors, as well as through the United States Veterans Health Administration (the VHA).

AbbVie Inc. Stock Outperforms Market Despite Losses On The Day

4:33 pm ET November 2, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) slid 1.63% to $144.52 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.50% to 3,759.69 and Dow Jones Industrial Average falling 1.55% to 32,147.76. AbbVie Inc. closed $31.39 short of its 52-week high ($175.91), which the company achieved on April 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) fell 1.96% to $47.07, Eli Lilly & Co. (LLY) rose 0.68% to $354.96, and AstraZeneca PLC ADR (AZN.LN) fell 0.25% to $59.70. Trading volume (5.3 M) remained 199,275 below its 50-day average volume of 5.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 2, 2022.

(END) Dow Jones Newswires

November 02, 2022 16:33 ET (20:33 GMT)

Premarket

Change Since Close

Market Hours

AbbVie Inc. Stock Outperforms Market Despite Losses On The Day